2008
DOI: 10.1111/j.1467-2995.2007.00370.x
|View full text |Cite
|
Sign up to set email alerts
|

Effects of isoflurane on echocardiographic parameters in healthy dogs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

7
24
3
1

Year Published

2009
2009
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 32 publications
(35 citation statements)
references
References 19 publications
7
24
3
1
Order By: Relevance
“…Left EDVs were higher, ESVs were lower; left ventricular stroke volume and EFs were higher using echocardiography in the awake animals compared to any of the anesthesia modality combinations, even though there was overlap. These findings are consistent with those found in previous studies in isoflurane‐anesthetized dogs . A recent study compared echocardiographic measurement of the left ventricular volume using the Teicholz and modified Simpson method to left ventricular volumes acquired using dual‐source CT and applying the Simpson method in seven propofol/isoflourane‐anesthetized dogs using medetomedine as premedication.…”
Section: Discussionsupporting
confidence: 89%
See 1 more Smart Citation
“…Left EDVs were higher, ESVs were lower; left ventricular stroke volume and EFs were higher using echocardiography in the awake animals compared to any of the anesthesia modality combinations, even though there was overlap. These findings are consistent with those found in previous studies in isoflurane‐anesthetized dogs . A recent study compared echocardiographic measurement of the left ventricular volume using the Teicholz and modified Simpson method to left ventricular volumes acquired using dual‐source CT and applying the Simpson method in seven propofol/isoflourane‐anesthetized dogs using medetomedine as premedication.…”
Section: Discussionsupporting
confidence: 89%
“…The IVSs measurement was larger when evaluated using echocardiography in the awake dogs, possibly indicating higher contractility in the awake compared to anesthetized dog as shown in previous reports in isoflurane‐anesthetized dogs; this effect was present but weaker for LVPWs. Similarly, the fractional shortening was greater and LVIDs was lower in the awake dogs compared to either of our anesthesia protocols, most likely due to the background of isoflurane in all dogs . The aortic and pulmonary artery diameter was larger in the awake vs. anesthetized patients.…”
Section: Discussionsupporting
confidence: 55%
“…Although some studies have demonstrated that it may be dependent on heart rate (Poulsen et al 2000), previous studies in healthy dogs and in human beings also documented an absence of correlation with such parameter (Sousa et al 2007). More studies are needed to better clarify the dependency of these two measurements, as the influence of heart rate in the Tei index remains controversial and could potentially preclude its use in dogs presenting tachyarrhythmias.…”
Section: Discussionmentioning
confidence: 94%
“…In dogs with myxomatous mitral valve disease, it increased with the progression of clinical signs, apparently because of the shortening of the ejection time resulting from the reduction in forward stroke volume (Teshima et al 2007). In a study in which 16 healthy adult dogs undergoing isoflurane anesthesia were enrolled, the index demonstrated to be a heart rate-independent predictor of impaired global myocardial function (Sousa et al 2007).…”
Section: Discussionmentioning
confidence: 99%
“…Entre os agentes halogenados, observa-se, proporcionalmente, um índice mais elevado de mortalidade para o isofluorano do que para o halotano. Entretanto, o isoflurano apresenta menor tempo de indução e recuperação, menor depressão cardiorrespiratória, sendo marcadamente mais seguro em relação ao halotano para manutenção da função cardiovascular, apesar de estudos ecocardiográficos demonstrarem que 1 CAM de isofluorano é capaz de produzir efeito depressor significante do miocárdio (SOUSA et al, 2008). Sugerese que este índice de mortalidade maior para fármacos comprovadamente mais seguros esteja relacionado a uma maior aplicação desses agentes em pacientes com comprometimento sistêmico (ASA III a V) e hemodinamicamente comprometidos, conforme descrito por CARARETO et al (2005), em um estudo em que um maior índice de mortalidade foi observado com a utilização do sevoflurano.…”
Section: Resultsunclassified